3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT6 receptor modulators
作者:Ronald C. Bernotas、Schuyler Antane、Rajesh Shenoy、Van-Duc Le、Ping Chen、Boyd L. Harrison、Albert J. Robichaud、Guo Ming Zhang、Deborah Smith、Lee E. Schechter
DOI:10.1016/j.bmcl.2010.01.073
日期:2010.3
6 were synthesized as potential 5-HT6receptor ligands, based on constraining a basic side chain as either a piperidine or a pyrrolidine. Many of these compounds had good 5-HT6 binding affinity with Ki values <10 nM. Depending on substitution, both agonists (e.g., 6o: EC50 = 60 nM, Emax = 70%) and antagonists (6y: IC50 = 17 nM, Imax = 86%) were identified in a 5-HT6 adenylyl cyclase assay.
1-Heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
申请人:Bernotas Charles Ronald
公开号:US20060030593A1
公开(公告)日:2006-02-09
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
本发明提供了一种I式化合物及其用途,用于治疗与5-HT6受体相关或受其影响的中枢神经系统疾病。
1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
申请人:Wyeth
公开号:US06995176B2
公开(公告)日:2006-02-07
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.